Research/art/teacher profile of a person
Name and surname:
Mgr. Agáta Očenášová
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Očenášová
I.2 - Name
Agáta
I.3 - Degrees
MSc.
I.4 - Year of birth
1994
I.5 - Name of the workplace
Institute of Immunology, Faculty of Medicine, Comenius University Bratislava
I.6 - Address of the workplace
Odborárske námestie 14, 811 08 Bratislava
I.7 - Position
PhD student
I.8 - E-mail address
agata.ocenasova@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
PhD student
I.10 - Name of the study field in which a person works at the university
Medical Microbiology and Immunology
I.11 - ORCID iD
0009-0002-4397-5310

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Natural Sciences
II.b - Year
2016
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Faculty of Natural Sciences
II.b - Year
2019
II.c - Study field and programme
Molecular Biology
II.3 - Third degree of higher education
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Laboratory Diagnostician Medirex a.s., Bratislava 2020-2022

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Immunology General Medicine 2nd Degree General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
8
VI.1.b - Over the last six years
8
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
4
VI.1.b - Over the last six years
4
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
10
VI.1.b - Over the last six years
10
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)

2

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)

3

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)

4

Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34. (IF = 3,7; Q2)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)

2

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)

3

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)

4

Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34.(IF = 3,7; Q2)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.

cited by: Pintér P, Alpár A. The Role of Extracellular Matrix in Human Neurodegenerative Diseases. International journal of molecular sciences 2022;23(19):11085. (Q1)

2

article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.

cited by: Xu Y, Yan H, Zhang X, et al. Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer's Disease. Frontiers in endocrinology. 2022;13:876269. (Q1)

3

article: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105.

cited by: Shang X, Maimaiti N, Fan J, et al. Triggering Receptor Expressed on Myeloid Cells 2 Mediates the Involvement of M2-Type Macrophages in Pulmonary Tuberculosis Infection. Journal of inflammation research. 2024;17:1919-1928. (Q2)

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

part of the research team - VEGA 1/0738/20 - Biomarkers of neuroinflammation in patients with Alzheimer's disease

2

responsible investigator of the grant - UK/245/2022 - Genetic polymorphisms in the promoter regions of MMP2 and the risk of developing Alzheimer's disease in the Slovak population

3

responsible investigator of the grant - UK/301/2023 - Genetic polymorphisms in the regulatory regions of the HLAG gene and the risk of developing Alzheimer's disease in the Slovak population

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2024-05-05